American pharmaceutical giant Eli Lilly has tapped Huntsville, Alabama, as the location for its third orforglipron ...

reported better-than-expected earnings for the fourth quarter. The Indianapolis, Indiana-based company posted quarterly earnings of $428.5 million, or $0.40 per share, compared to $727.5 million, or ...

Eli Lilly's shares have increased by about 10% over the past month. Clinical progress in the past few weeks has helped solidify its lead in the weight loss market. The company's prospects remain ...

Eli Lilly's GLP-1 drug portfolio should power the business for at least the next decade. But the market appears well aware of the company's weight loss drug success. Weight loss drugs are set to ...